Tag archive for ‘sensorineural hearing loss’
MSCP wraps up $330m sale of majority stake in Hojeij Branded Foods to Lagardere
By pharmanewsdaily On Sunday, July 26th, 2020

PIPE-505 : Pipeline Therapeutics initiates phase 1/2a SNHL trial

Pipeline Therapeutics has initiated a phase 1/2a trial of PIPE-505, which is a small molecule gamma secretase inhibitor (GSI), in patients who have sensorineural hearing loss (SNHL) associated with hearing speech More...